Comparison of Inhaled Corticosteroids: An Update

H William Kelly, PharmD

Disclosures

The Annals of Pharmacotherapy. 2009;43(3):519-527. 

In This Article

Summary

Inhaled corticosteroids all share properties that make them effective topical antiinflammatory agents for treatment of asthma with minimal adverse systemic effects, particularly when administered in low- to medium-dose ranges. The EPR3 has provided the clinician with a comparative dosing chart based on comparative clinical trials. While there are differences among the inhaled corticosteroids in pharmacokinetic properties that can improve the therapeutic indexes, this has not yet been adequately assessed in comparative dose-ranging studies to make firm conclusions.


CLICK HERE for more information about this journal.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....